Loading
You are here: Home » Health Issues » Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen

Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen

August 5th, 2010 | Health News Category : Health Issues,Pharma

Genzyme Corp. (NASDAQ: GENZ) and Isis Pharmaceuticals Inc. (NASDAQ: ISIS) announced results of two phase 3 studies of mipomersen in patients who had high cholesterol levels while on maximally tolerated lipid-lowering therapy.

Original Source of Genzyme and Isis Report Results of Two Phase 3 Trials of Mipomersen

Related Health Article

    Related tweets from Twitter:

    • mariaconzemius : Can someone explain to me how birth control pills can be considered basic health care? It doesn't make sense to me.
      2012-02-12T23:24:08Z - Reply - View Tweet
    • WayneTCortez : Zac Efron: 'Thousands of Calories' for 'The Lucky One' http://t.co/2TTNi5Mz #dieting #health
      2012-02-12T23:24:07Z - Reply - View Tweet
    • breizh2008 : Preventive Medicine Can Save Your Life http://t.co/ZvFV2WOP
      2012-02-12T23:24:06Z - Reply - View Tweet
    • HealthCareShake : #HealthCareShake Republicans sign on to legal brief in challenge to Obama's federal health care ... http://t.co/97MLx4rr
      2012-02-12T23:24:05Z - Reply - View Tweet
    • katloveslovato : RT @LovaticEpicness: Lol you guys need to realize that without Demi's health there is no Demi music. SO CHILL OUT.
      2012-02-12T23:24:05Z - Reply - View Tweet

    Add this post to your favorites social bookmark

    Bookmark and Share